AVALON GLOBOCARE CORP

Avalon GloboCare Corp is a biotechnology company that is focused on the development and commercialization of cell-based therapies and precision medicine. The company is based in Freehold, New Jersey and was founded in 1999.

Avalon GloboCare's primary business segments include cellular therapy and precision medicine. The company is focused on developing and commercializing advanced cell-based therapies for a range of diseases and conditions, including cancer, autoimmune disorders, and cardiovascular diseases. Avalon GloboCare also has a strong focus on precision medicine, using advanced genomic and proteomic technologies to develop personalized treatments for patients.

One of the key strengths of Avalon GloboCare is their focus on innovation. The company invests heavily in research and development, with a focus on developing new and improved cell-based therapies and precision medicine solutions that can meet the evolving needs of the healthcare industry. This approach has allowed Avalon GloboCare to stay at the forefront of the rapidly-evolving biotechnology industry.

In addition to their focus on innovation, Avalon GloboCare also places a strong emphasis on collaboration. The company works closely with academic institutions, pharmaceutical companies, and other partners to develop and commercialize new products and solutions. This collaborative approach has helped Avalon GloboCare to build strong relationships with key stakeholders in the biotechnology industry.

Financially, Avalon GloboCare has recently undergone a reverse stock split, consolidating every 10 ordinary shares into 1 ADS, with the purpose of meeting the NASDAQ listing requirements. The company’s ADSs are publicly traded on the NASDAQ stock exchange under the ticker symbol AVCO.

Avalon GloboCare Corp is a biotechnology company that is focused on the development and commercialization of cell-based therapies and precision medicine. The company's focus on innovation, collaboration, and strong financial performance make them an attractive partner for academic institutions, pharmaceutical companies, and other stakeholders in the biotechnology industry. With their extensive experience and investment in R&D, Avalon GloboCare is well-positioned to continue to develop innovative solutions that can help advance healthcare and improve the lives of patients around the world.

YES YOU CAN GO

AXIOM YOU ART